|
See related Renvela film-coated tab information |
|
|
|
Manufacturer |
Genzyme |
|
Distributor |
DKSH |
|
Contents |
Anhydrous sevelamer carbonate |
|
Indications |
Control of serum P in patients w/ chronic kidney disease (CKD) on dialysis.
Click to view Renvela detailed prescribing infomation |
|
Dosage |
Patients not taking a phosphate binder w/ serum P ≥9, ≥7.5 & <9 mg/dL 2 tab. >5.5 & <7.5 mg/dL 1 tab. All doses to be taken tid. Patients switching from sevelamer HCl Titrate further to desired phosphate levels up to max 14 g/day. Patients switching from Ca acetate 1 tab Ca acetate 667 mg equiv to 1 tab Renvela 800 mg. Dose titration for all patients may be increased/decreased by 1 tab/meal at 2 wk intervals to reach serum P 3.5-5.5 mg/dL.
Click to view Renvela detailed prescribing infomation |
|
Overdosage |
View Renvela overdosage for action to be taken in the event of an overdose. |
|
Administration |
Should be taken with food |
|
Contraindications |
Hypophosphatemia or bowel obstruction.
Click to view Renvela detailed prescribing infomation |
|
Special Precautions |
GI disorders. Monitor bicarbonate & Cl levels, reduced vit D, E, K & folic acid levels.
Click to view Renvela detailed prescribing infomation |
|
Adverse Drug Reactions |
Vomiting, nausea, diarrhea, dyspepsia, abdominal pain, flatulence, constipation, peritonitis.
View ADR Monitoring Form |
|
Drug Interactions |
Ciprofloxacin, levothyroxine, antiarrhythmics, anti-seizure drugs.
View more drug interactions with Renvela |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
Storage |
View Renvela storage conditions for details to ensure optimal shelf-life. |
|
Description |
View Renvela description for details of the chemical structure and excipients (inactive components). |
|
Mechanism of Action |
View Renvela mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Renvela film-coated tablet |
|
|
|
Manufacturer: |
Genzyme |
|
Distributor: |
DKSH
|
|
|
|
